Would you take a weekly injection for the rest of your life if it meant never worrying about weight again? This important conversation looks beyond individual willpower to the systems that influence our eating habits.

GLP‑1 medications such as Ozempic, Wegovy, and Mounjaro are reshaping how Americans think about appetite, health, and the food around us. As more people use these drugs, the food industry is already responding — from new “GLP‑1‑friendly” products to shifting marketing strategies. But the rise of GLP‑1s also raises deeper questions. What happens when medication becomes one of the most effective ways to navigate a food system built around overconsumption? How might these drugs change what we eat, how companies design and sell food, and the broader incentives that shape our choices?

Boston Globe health and science writer Robert Weisman moderates a discussion with Marion Nestle, leading scholar of food politics; Trey Malone, agricultural economist; and Alexandra Brewis, a global health anthropologist. Together, they explore what a healthier, more ethical food future might require.